ArticleSurgical case reports2025
A Resected Case of Hepatic Angiomyolipoma with Tumor Hemorrhage and Undetectable Fat Causing Diagnostic Difficulty.
Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHepatic angiomyolipoma (AML) is a rare, benign mesenchymal tumor with variable imaging features, often complicating differentiation from malignancy. We report a case of hepatic AML that showed progressive enlargement due to intratumoral hemorrhage, without detectable fat on imaging. CASE PRESENTATION: A woman in her 70s with no history of chronic liver disease had previously undergone surgery for lung adenocarcinoma and for localized nodular hyperplasia of the liver. Routine follow-up imaging revealed an enlarging liver mass in the right hepatic lobe, leading to her referral for further evaluation. Tumor markers were within normal ranges, and liver function remained intact. Non-contrast CT showed a low-attenuation nodule, and contrast-enhanced CT demonstrated ring-like peripheral enhancement with a hypovascular center. Magnetic resonance imaging showed low signal on T1-weighted images and high signal on T2-weighted images, with no signal loss in opposed-phase imaging. Ultrasonography demonstrated a low echogenicity within the tumor and high echogenicity in the surrounding area, with no clear contrast effect. The preoperative diagnosis suggested either a hematoma or a necrotic nodule. Given the progressive growth and inconclusive imaging, malignancy could not be excluded. A laparoscopic hepatectomy was performed for definitive diagnosis. The resected tumor was a 2.3 × 2.0 × 1.4 cm well-demarcated, light brown mass with areas of hemorrhage and cystic change. Histopathology confirmed hepatic AML with tumor hemorrhage and extramedullary hematopoiesis.
conclusionsHepatic AML may exhibit progressive growth despite lacking typical imaging features such as intratumoral fat or vascularity, making preoperative diagnosis difficult. In cases where malignancy cannot be ruled out, surgical resection should be considered after careful evaluation of both benign and malignant possibilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.